Novavax 2022 COVID vaccine deliveries off to slow start, shares drop Ruchika Sharma11 May 2022 9:00 AM ISTNew Delhi: Novavax Inc on Monday revealed a sharp drop in first-quarter COVID-19 research funding and said it shipped less than a fourth of the total...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 11:00 AM ISTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
Serum Institute Covovax price slashed to Rs 225 Per Dose Roshni Dhar4 May 2022 5:51 PM ISTA day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the...
Health Bulletin 4/May/2022 Roshni Dhar4 May 2022 5:24 PM ISTHere are the top health stories for the day: Mandatory yoga for MBBS: NMC releases common yoga protocol to be followed by allReferring to...
Serum Institute Covovax price cut to Rs 225 per dose Ruchika Sharma4 May 2022 1:26 PM ISTThe price of the vaccine, Covovax, is learnt to have been revised on the CoWIN portal.
USFDA VRBPA committee to review Novavax COVID vaccine Ruchika Sharma2 May 2022 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2.
Early trial of Novavax COVID-Influenza vaccine shows promise Ruchika Sharma23 April 2022 10:00 AM ISTThe safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...
Novavax partner gets Japenese nod for Nuvaxovid Ruchika Sharma19 April 2022 5:18 PM ISTNovavax licensed and transferred its manufacturing technologies and is supplying the Matrix-M adjuvant to enable Takeda to manufacture the vaccine at...
Novavax seeks conditional marketing nod for Nuvaxovid in adolescents Ruchika Sharma3 April 2022 9:00 AM ISTGaithersburg: Novavax, Inc. has announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid COVID-19...
SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Novavax's COVID vaccine rollout in EU off to a slow start -data MD Bureau15 March 2022 2:42 PM ISTThe Novavax vaccine, the latest to receive the EU regulators' approval under the trade name of Nuvaxovid, was expected to persuade some sceptics...
